posted on 2013-02-15, 00:00authored byZiqing Qian, Tao Liu, Yu-Yu Liu, Roger Briesewitz, Amy M. Barrios, Sissy
M. Jhiang, Dehua Pei
Cyclic peptides hold great potential as therapeutic agents
and
research tools, but their broad application has been limited by poor
membrane permeability. Here, we report a potentially general approach
for intracellular delivery of cyclic peptides. Short peptide motifs
rich in arginine and hydrophobic residues (e.g., FΦRRRR, where
Φ is l-2-naphthylalanine), when embedded into small-
to medium-sized cyclic peptides (7–13 amino acids), bound to
the plasma membrane of mammalian cultured cells and were subsequently
internalized by the cells. Confocal microscopy and a newly developed
peptide internalization assay demonstrated that cyclic peptides containing
these transporter motifs were translocated into the cytoplasm and
nucleus at efficiencies 2–5-fold higher than that of nonaarginine
(R9). Furthermore, incorporation of the FΦRRRR motif
into a cyclic peptide containing a phosphocoumaryl aminopropionic
acid (pCAP) residue generated a cell permeable, fluorogenic probe
for detecting intracellular protein tyrosine phosphatase activities.